Dietary interventions in prostate cancer

Current Urology Reports

Volumn 9, Issue 3, 2008, Pages 217-225

  Demark Wahnefried, Wendy ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; PLACEBO; RETINOL; SELENIUM; SELENOMETHIONINE;

BIOAVAILABILITY; BODY MASS; CANCER CONTROL; CANCER MORTALITY; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG FATALITY; EXERCISE; FUNCTIONAL FOOD; HUMAN; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; NONHUMAN; OBESITY; PROSTATE CANCER; REVIEW; RISK REDUCTION; SMOKING; VITAMIN SUPPLEMENTATION; WEIGHT CONTROL;

DIETARY SUPPLEMENTS; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 44449172419     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0038-8     Document Type: Review

References (50)

1. Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66:1191-1308.
2. • Aggarwal BB, Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397-1421. An extensive review that provides a solid overview of potential molecular targets for dietary interventions as they relate to cancer overall.
3. • Chan JM, Gann PH, Giovannucci EL: Role of diet in prostate cancer development and progression. J Clin Oncol 2005, 23:8152-8160. A comprehensive review of epidemiologic investigations of prostate cancer.
4. Demark-Wahnefried W, Moyad MA: Dietary intervention in the management of prostate cancer. Current Opin Urol 2007, 17:168-174.
5. Fleshner N, Zlotta AR: Prostate cancer prevention: past, present, and future. Cancer 2007, 110:1889-1899.
6. Shukla S, Gupta S: Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 2005, 53:18-32.
7. Thompson IM, Tangen CM, Klein EA, Lippman SM: Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol 2005, 23:8161-8164.
8. • Canby-Hagino, Thompson IM: Mechanism of disease: prostate cancer - a model for cancer chemoprevention in clinical practice. Nature Clin Pract Oncol 2005, 2:255-261. A targeted review of select pathways and the potential impact of dietary interventions.
9. Lamb DJ, Zhang L: Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease progression. J Nutr 2005, 135(12 S):3009S-3015S.
10. •• Department of Health and Human Services, US Department of Agriculture: Dietary guidelines for Americans, 2005. Accessible at http://www.health.gov/dietaryguidelines. Accessed on January 2007. This resource features the most recent guidelines (updated from 2001). Although not prostate cancer-specific, general guidelines are provided for dietary patterns, food intake, and physical activity, with accompanying rationale.
11. Pryor WA, Stahl W, Rock CL: Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000, 58:39-53.
12. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J M 1994, 330:1029-1035.
13. Omenn GS, Goodman GE, Thornquist MD, et al.: Risk factors for lung cancer and the intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996, 88:1550-1559.
14. Weinstein SJ, Wright ME, Lawson KA, et al.: Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:1253-1259.
15. • Bairati I, Meyer F, Jobin E, et al.: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006, 119:2221-2224. One of the largest trials to explore the combination of high-dose antioxidants with standard cancer treatment. The adverse impact of the combination should encourage clinicians to caution supplement use during radiation therapy until more research is completed.
16. Miller ER III, Pastor-Barriuso R, Dalal D, et al.: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
17. Potter JD: Food and Cancer Prevention II: summary of the meeting. Cancer Letters 1997, 114:337-38.
18. •• Bjelakovic G, Nikolova D, Glund LL, et al.: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297, 842-857. A comprehensive review of antioxidant use and cancer that includes a meta-analysis of data from 68 randomized controlled trials. Findings suggest that whereas vitamin C and selenium have no significant impact on mortality, increased risk was found for beta-carotene.
19. • Lawson KA, Wright ME, Subar A, et al.: Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007, 99:754-764. This study of 295,344 older adults was the first large study to report a significantly negative association between multivitamin use and aggressive prostate cancer.
20. Food and Nutrition Board/National Academy of Sciences/Institutes of Medicine. Dietary Reference Intakes. Accessible at http://www.iom.edu/ Object.File/Master/21/372/0.pdf. Accessed on January 10, 2008.
21. Reid ME, Stratton MS, Lillico AJ, et al.: A report of high-dose selenium supplementation: response and toxicities. J Trace Elements Med Biol 2004, 18:69-74.
22. Williams R, Ansford A: Acute selenium toxicity: Australia's second fatality. Pathol 2007, 39:289-290.
23. Bemis DL, Capodice JL, Costello JE, et al.: The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer. Current Oncol Reports 2006, 8:228-236.
24. Schmid HP, Engeler DS, Pummer K, Schmitz-Drager BJ: Prevention of prostate cancer: more questions than data. Recent Results Cancer Res 2007, 174:101-107.
25. Ansari MS, Gupta NP: A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. Br J Urol Int 2003, 92:375-378.
26. Bunker CH, McDonald AC, Evans RW, et al.: A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer 2007, 57:130-137.
27. Kucuk O, Sarkar FH, Sakr W, et al.: Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001, 10:861-868.
28. Hoenjet KM, Dagnelie PC, Delaere KP, et al.: Effect of a nutritional supplement containing vitamin E, selenium, vitamin C and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Euro Urol 2005, 47:433-439.
29. Kranse R, Dagnelie PC, van Kernende MC, et al.: Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled trial. Int J Cancer 2005, 113:835-840.
30. Schröder FH, Roobol MJ, Boevé ER, et al.: Randomized double blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Euro Urol 2005, 48:922-931.
31. Hamilton-Reeves JM, Rebello SA, Thomas W, et al.: Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen-beta expression or serum hormonal profiles in men at high risk of prostate cancer. J Nutr 2007, 137:1769-1775.
32. Kumar NB, Cantor A, Allen K, et al.: The specific role of isoflavones in reducing prostate cancer risk. Prostate 2004, 59:141-147.
33. Dalais FS, Meliala A, Wattanapenpaiboon N, et al.: Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urol 2004, 64:510-515.
34. Bylund A, Lundin E, Zhang JX, et al.: Randomised controlled short-term intervention pilot study on rye bread in prostate cancer. Euro J Cancer Prevent 2003, 12:407-415.
35. • Ornish D, Weidner G, Fair WR, et al.: Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005, 174:1065-1070. This is the largest completed and published randomized trial conducted to date in the area of diet and prostate cancer. Results are compelling, but it is unknown which of the multiple components is most beneficial, including weight loss, and which may have confounded the results.
36. • Lippman SM, Goodman PJ, Klein EA, et al.: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005, 97:94-102. This paper describes the rationale and study design of this hallmark dietary trial aimed at prostate cancer prevention.
37. • Marshall JR, Sakr W, Wood D, et al.: Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 2006, 15:1479-1484. This article describes the rationale and study design of an important dietary trial in prostate cancer.
38. Etminan M, FitzGerald JM, Gleave M, et al.: Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 2005, 16:1125-1131.
39. 2 unit increase in BMI there is an increased risk for advanced prostate cancer and overall disease.
40. Rodriguez C, Freedland SJ, Deka A, et al.: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2007, 16:63-69.
41. Wright ME, Chang SC, Schatzkin A, et al.: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007, 109:675-684.
42. •• Doyle C, Kushi LH, Byers T, et al.: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2006, 56:323-353. The American Cancer Society regularly assembles a panel of experts to review the literature related to diet and exercise and its role in the primary prevention of cancer, and its importance for cancer control and tertiary prevention among cancer survivors. This report reviews diet and exercise studies related to a spectrum of cancer survivors (including survivors of prostate cancer) and issues guidelines for informed choices.
43. •• World Cancer Research Fund/American Institute for Cancer Research: Second Expert Report, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007. This report chronicles a systematic and comprehensive review from the world's leading scientists in the area of diet and cancer.
44. Halabi S, Ou SS, Vogelzang NJ, Small E: Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer. Cancer 2007, 110:1478-1484.
45. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al.: Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metabol Care 2007, 10:433-442.
46. Laviano A, Meguid MM, Inui A, et al.: Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nature Clin Pract Oncol 2005, 2:158-165.
47. Podgorski I, Linebaugh BE, Sloane BF: Cathepsin K in the bone microenvironment: link between obesity and prostate cancer? Biochem Soc Transactions 2007, 35:701-703.
48. • DeMarzo AM, Platz EA, Sutcliffe S, et al.: Inflammation in prostate carcinogenesis. Nature Rev Cancer 2007, 7:256-269. A comprehensive review (158 references) that addresses the interplay between obesity and inflammation and its potential impact on prostate cancer.
49. • Freedland SJ, Platz EA: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007, 29:88-97. A thorough review (123 references) on the topic of obesity and prostate cancer.
50. Demark-Wahnefried W, Aziz N, Rowland J, Pinto BM: Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005, 23:5814-5830.